Porsche Cayenne Awd 4dr S Hybrid Low Miles Suv Automatic 3.0l V6 Cyl White on 2040-cars

Auto blog

McLaren rules out Porsche Cayman competitor

McLaren has gone downmarket with the introduction of its new Sports Series, but don't expect it to go any lower than that. So while the 570S goes up against the Audi R8 and Porsche 911 Turbo, the likes of the TT and Cayman can rest easy. Speaking with Autocar, McLaren designer Robert Melville ruled out the prospect of developing a sports car positioned lower than the Sports Series. Melville dismissed the idea of a Cayman rival from Woking as "a step too far" and "not exclusive enough" for McLaren. "You look at Ferrari. They are coming from very high end. [The 570S] is stretching us down to R8s and 911s and is as low as we'd want to come." The limit may be dictated, more than anything, by the building blocks. The newly introduced Sports Series adopts the same essential hard points as the higher-end Super Series (650S) and Ultimate Series (P1). Like its more expensive siblings, it features a 3.8-liter twin-turbo V8 mated to a seven-speed dual-clutch transmission and bolted to the back of a carbon monocoque chassis. Only instead of selling for $265k like the 650S or over $1 million like the P1, the 570S will retail for under $190k. Volume is how the manufacturer aims to make up the difference. In fact McLaren stands to generate as much revenue (if not necessarily the same profit margin) selling 2,500 units in the Sports Series each year as it has producing all 375 examples of the P1. Making those same building blocks available at a lower price point – or developing an entirely new set – would be an entirely different proposition... one which McLaren is evidently less than keen to undertake. So while we can look forward to new versions of the Sports Series to follow – including Spider and GT variants soon to follow – more commonplace stablemate appears to be off the table. Related Video: Featured Gallery 2016 McLaren 570S: First Drive View 34 Photos News Source: AutocarImage Credit: Copyright 2015 AOL McLaren Porsche Performance Supercars mclaren 570s mclaren sports series

Porsche 911 with VW turbodiesel prepares for LeMons assault

LeMons racing is a wonderful example that setting limits can actually breed creativity. The series mandates that all entries must cost $500, not counting safety equipment, and that cap forces teams to be ingenious in how they build a racecar. Take for example this diesel-powered Porsche 911, which its creators have dubbed Ferkel the Nein-11, that will be racing in the Sears Pointless race this weekend in Sonoma, California.
This Frankenstein combines a 911 chassis that was originally bought just for its European powertrain and a Volkswagen TDI diesel engine mounted in the rear. After deciding the shell could still be of some use, the team decided to go racing. "We began brainstorming what replacement drivetrain to use for maximum offense and there was really only one answer: a diesel," said Philipp von Weitershausen, one of the team captains, to Jalopnik. They bought a 1998 Jetta TDI on the cheap and started figuring out a way to hack the engine into the bay. To pay respect to the donor, the VW's trunk was highly modified (and drilled) and grafted onto the back of Ferkel.
This team isn't a newcomer to LeMons. Its last car was a classic VW Beetle with a Subaru engine and dual controls, named Ferdinand the Bug, which could be driven from the left or right side. It's quite a sight.

Porsche suspends ties with Maria Sharapova after drug test

Porsche has reportedly suspended ties with Maria Sharapova after the Russian tennis star failed a drug test. The German automaker stopped short of terminating its relationship with the athlete altogether as it awaits the results of a deeper investigation. The issue emerged at the Australian Open, where Sharapova reportedly tested positive for use of a drug called meldonium. Manufactured in Latvia and prescribed in many former Soviet Bloc countries, meldonium is used to treat heart conditions and improve cardiac circulation. It is not approved by the FDA for use in the United States, and the World Anti-Doping Agency added it to its list of prohibited substances at the start of this year. Sharapova admitted that she's been taking the medication for ten years now but that she did not keep up to date on the WADA's list. Since it is considered a prohibited substance, she's been excluded from participating in the Australian Open this year, and suspended from competition as of March 12. She was also scheduled to take part in the Porsche Grand Prix, a tennis event sponsored by the carmaker in Stuttgart next month which she will now apparently have to miss. One of the top-rated female tennis players in the world, Sharapova has served as a brand ambassador for Porsche since 2013. Other sponsors including TAG Heuer and Nike have also reportedly suspended their relationships with the athlete pending further investigation by the International Tennis Federation. Related Video: